Filings buzz in pharmaceuticals: 47% increase in big data mentions since Q2 of 2021

Mentions of big data within the filings of companies in the pharmaceutical industry were 47% higher in the second quarter of 2022 than in Q2 of 2021.

In total, the frequency of sentences related to big data between July 2021 and June 2022 was 105% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.